🧫 Hantavirus - Apr 2026 • Hantaan virus detected in 8.4% of Apodemus agrarius in tri-border region • High case fatality rate among adolescents aged 15-19 in Southern Brazil • Hantavirus L protein shows host shutoff activity • AMRV found in 6.3% of A. peninsulae pir.sh/OKY136Xgr4

💗 Breast Cancer - Apr 2026 • Two immune landscapes in brain metastases predict patient survival • Alpelisib + fulvestrant improves PFS in PIK3CA-altered breast cancer • BUSGen AI model improves breast ultrasound screening outcomes pir.sh/l06avZzanL #BreastCancer #Oncology

🦠 Gut Microbiome - Apr 2026 • GMB taxa predict recurrence-free survival under immune checkpoint blockade • Engineered Lactobacillus reduces ammonia and improves cognition in HE models • Bifidobacterium boosts antidepressant effects of creatine pir.sh/KLV1e3AaGw #GutMicrobiome #Microbiome

🦠 Long COVID - Apr 2026 • 30% of long COVID patients show neurological symptoms 4+ months post-infection • Severe COVID linked to impaired cognition up to 32 months post-diagnosis • Long COVID economic burden estimated at $1 trillion annually pir.sh/zXe1RVw1nB #LongCOVID

🩸 Liquid Biopsy - Apr 2026 • ctDNA clearance predicts treatment efficacy in large B-cell lymphoma • Platelets emerging as biomarker for ovarian cancer detection • KIM-1 levels correlate with treatment response in renal cell carcinoma pir.sh/32p176rgwv #LiquidBiopsy #CancerDiagnostics

🩸 Leukemia - Apr 2026 • High CD81 expression linked to AML treatment resistance • Pediatric AML outcomes improve with refined risk stratification • TCR therapy targeting Cathepsin G shows strong cytotoxicity in AML • MYB activity drives enhancer activation in leukemia pir.sh/mq2dpKK1l4 #Leukemia

🪴 Stem Cells - Apr 2026 • p53 essential for chemical reprogramming of somatic cells into iPSCs • CRISPR-Cas12a shows promise in transfusion-dependent β-thalassemia • Spatial 5mC-seq reveals DNA methylation heterogeneity in embryonic development pir.sh/4B31yLpgzG #StemCells #Epigenetics

🩸 Diabetes - Apr 2026 • Semaglutide cuts cardiovascular events by 20% in obesity with CVD • Youth-onset T2D rising sharply • Cagrilintide + semaglutide achieves 18.7% mean weight loss • Low-plastic diet reduces harmful cardiometabolic chemicals pir.sh/9XygJJqg3w #Diabetes

🫧 Extracellular Vesicles - Apr 2026 • HCC-derived EVs promote lung metastasis via ITGα24 signaling • 5-HIAA from EVs remodels vasculature to enable leptomeningeal metastasis • Senescent hepatocyte EVs enhance metastasis via miRNA release pir.sh/A5kgYV814m #ExtracellularVesicles

🌍 One Health - Apr 2026 • Slaughtered swine identified as hotspots for antimicrobial-resistant E. coli • Soil microbial diversity reduces prevalence of human bacterial pathogens • Non-human A. baumannii shows greater diversity, raising public health concern pir.sh/xMNdAQMd6e #OneHealth

🫂 Radiogenomics - Apr 2026 • BIOMEDE trial: no survival benefit adding targeted therapies to radiotherapy in DIPG • Low-dose radiotherapy + ICB achieves 42% disease control in immune-excluded tumors • sTILs added to PREDICT model improve chemotherapy decisions pir.sh/RbZ1DnoajK #Radiogenomics

🧠 Alzheimer's & Microglia - Apr 2026 • Somatic cancer variants in microglia may drive Alzheimer's inflammation • PAD2 in astrocytes worsens amyloid pathology via microglial activation • Microglia uptake and release tau aggregates, seeding neuronal spread pir.sh/rk9156mdnp #Alzheimer #Microglia

✂️ Gene Editing - Apr 2026 • Reni-cel boosts neutrophil engraftment and fetal hemoglobin in β-thalassemia • Electromagnetic field switch enables precise in vivo gene control • Amino acid lipids enable efficient pulmonary CRISPR delivery pir.sh/qmxdxBvgyp #GeneEditing #CRISPR

🦠 Melanoma - Apr 2026 • Gut microbiome predicts recurrence-free survival under immune checkpoint blockade • High CD44 expression predicts multi-treatment resistance in melanoma • GPNMB drives brain metastasis in melanoma, a potential therapeutic target pir.sh/JoZa06Z1Gy #Melanoma #Immunotherapy

🧠 Meningioma - Apr 2026 • Childhood cancer survivors face higher meningioma risk from therapy-related mutations • Dose-escalated radiation improves survival in high-risk meningiomas • Long-term DMPA use linked to multiple bone-invasive meningiomas pir.sh/zZXgk3Og2M #Meningioma #Neurooncology

📊 Bioinformatics - Apr 2026 • TaxVAMB improves metagenome binning with taxonomic integration • DNA methylation subtypes predict immunotherapy outcomes in mesothelioma • eSIG-Net predicts mutation-driven protein interaction changes pir.sh/Wl4dnGja0G #Bioinformatics #ComputationalBiology

🧠 Neuro Oncology - Apr 2026 • BIOMEDE trial for DIPG halted due to futility • Combination therapies prolong survival in diffuse midline glioma • Two immune landscapes in BCBM predict survival • Microglial responses to glioblastoma invasion found to be biphasic pir.sh/nKzaEkE1Jp #NeuroOncology

✂️ Gene Editing Highlights - Mar 2026 • YOLT-101 gene therapy cuts LDL cholesterol in familial hypercholesterolemia • Adenine base editors show enhanced on-target editing capabilities • Evo 2 AI enhances genome editing prediction and design pir.sh/zZXgkQXd2M #GeneEditing #CRISPR

🫧 Extracellular Vesicles - Mar 2026 • Immune cells regulate adipocyte EV levels • Novel EV detection method achieves high sensitivity in cancer diagnosis • EV dynamics may serve as biomarkers for cognitive decline pir.sh/Wl4dnnvd0G #ExtracellularVesicles

🧠 Neuro Oncology Research Highlights - Mar 2026 • ERADECs outperform antibodies in PD-L1 degradation and tumor suppression • STANM achieves 200-fold drug concentration increase at tumor sites • Structural variants drive 60%+ of pediatric cancer mutations pir.sh/pzy1bxPalv #NeuroOncology

🧠 Meningioma Research Highlights - Mar 2026 • Panobinostat shows efficacy in 70% of meningioma organoids • PD-L1 positivity flags hyperaggressive meningioma subgroup • Molecular-morphologic classification improves radiotherapy timing pir.sh/nKzaE7Q1Jp #Meningioma #Neurooncology

📊 Bioinformatics - Mar 2026 • CellVoyager AI agent autonomously analyzes scRNA-seq data • Structural variants drive 60%+ of pediatric cancer mutations • ANNEVO improves gene annotation across diverse genomes pir.sh/z0odQ2baLO #Bioinformatics #ComputationalBiology

🩸 Liquid Biopsy - Feb 2026 • Pan-cancer analysis identifies 14,202 methylation regions for cancer detection • Multi-omics integration boosts cancer detection sensitivity in PROMISE study • M-PACT classifies pediatric CNS tumors from low-input cfDNA pir.sh/32p17rmgwv #LiquidBiopsy #ctDNA

🦠 Melanoma - Feb 2026 • Personalized mRNA vaccine shows durable reduction in melanoma recurrence • HOXD13 regulates angiogenesis and immune evasion in melanoma • Pepyrus boosts sensitivity in HLA-bound neoantigen discovery pir.sh/RbZ1DNrajK #Melanoma #Immunotherapy

✂️ Gene Editing - Feb 2026 • Protein2PAM boosts Cas9 PAM cleavage 50-fold • AAVLINK enables full-length protein expression beyond AAV packaging limits • Fusion peptides improve mRNA delivery and gene editing in vivo pir.sh/4B31yo4azG #GeneEditing #CRISPR

🧫 Microglia - Feb 2026 • BTK inhibition reduces neuroinflammation in ALS models • Microglia-T cell interactions drive neurodegeneration in Huntington's • TGF-β inhibition in microglia stimulates adult neurogenesis pir.sh/JoZa0Nr1Gy #Microglia #Neuroinflammation

🔬 Spatial Transcriptomics - Feb 2026 • CLIM-TIME maps 7 TME subtypes linked to T cell therapy response • Kupffer cells promote immune evasion in liver metastases • CD276 drives chemoresistance in pancreatic cancer • T cell activation correlate with better survival in glioblastoma pir.sh/9XygJ0Xd3w

🫧 Extracellular Vesicles - Feb 2026 • NE+ EVs drive chronic inflammation in COPD • RORγ-enriched exosomes alleviate diabetic kidney injury • EVs play key roles in metabolic regulation and disease pir.sh/xMNdAr2a6e #ExtracellularVesicles #CellBiology #Exosomes

💉 GLP-1 Agonists - Feb 2026 • GLP-1RAs reduce heart failure risk vs DPP-4 inhibitors • GLP-1RAs linked to optic neuropathy risk in younger patients • Semaglutide shows chondroprotective effects in osteoarthritis • Tirzepatide cuts major cardiovascular events vs placebo pir.sh/rk915rQdnp #GLP1

🧠 Meningioma - Feb 2026 • Tumor microenvironment challenges traditional meningioma classification • CDKN2A/B deletions linked to worse prognosis • Progestogen use raises intracranial meningioma risk • Y chromosome loss tied to higher tumor grades in males

🧬 Bioinformatics - Feb 2026 • Microbial dispersal identified as key driver of microbiome structure • 22-protein panel distinguishes MS from other inflammatory diseases • 134 mutational signatures identified across 16 cancer types pir.sh/pzy1b5yglv #Bioinformatics #ComputationalBiology #Genomics

🧬 Extracellular Vesicles — Jan 2026 • Inhalable and engineered EVs overcome immunotherapy resistance • EV-derived miRNAs reprogram macrophage phenotypes in cancer • Regenerative applications expand in cardiac, cartilage, and tendon repair #ExtracellularVesicles #Immunotherapy pir.sh/Wl4dn6Ad0G

🧠 Meningioma — Jan 2026 • Targeted therapies show mixed results in NF2-mutant disease • Epigenetic loss (H3K27me3) refines recurrence risk • AI imaging and intraoperative tools enhance classification and decision-making #Meningioma #NeuroOncology #BrainTumors pir.sh/pzy1bVy1lv

🧠 Neuro-Oncology — Jan 2026 • Spatial multi-omics reveals microenvironmental niches in glioma • Germline risk variants refine glioma susceptibility • CD47 destabilization and macrophage subsets expand immunotherapy angles #NeuroOncology #Glioma #BrainTumors pir.sh/nKzaEOK1Jp

🧠 Alzheimer Microglia — Jan 2026 • Distinct microglial states emerge with disease-specific gene programs • TREM2 and metabolic wiring shape microglial function in AD • Exosomes, miRNAs, and Aβ disaggregation explored as therapeutic angles pir.sh/z0odQxl1LO #Alzheimers #Microglia #Neuroscience

🩸 Diabetes — Jan 2026 • AI models improve continuous glucose prediction • GLP-1/GIP and SGLT2 therapies expand cardiometabolic impact • Genetic diversity and care disparities shape disease outcomes pir.sh/JoZa0MrgGy #Diabetes #Endocrinology #MetabolicHealth #PrecisionMedicine

🧬 Tumor Microenvironment — Jan 2026 • Engineered CAR-T and TAM targeting reshape local immunity • Fibroblast checkpoints and macrophage signaling drive resistance • DNA sensing and pyroptosis pathways amplify immunotherapy response pir.sh/9XygJPXd3w #TumorMicroenvironment #CancerImmunology #TAMs

🧫 Stem Cells — Jan 2026 • Developmental origin shapes fibroblast function and scarring • Stem and stromal plasticity influence tumor immunity • Metabolic stress impairs intestinal stem cell repair pir.sh/xMNdAR2a6e #StemCells #RegenerativeMedicine #DevelopmentalBiology #CellTherapy

🎗️ Melanoma — Recent Research • Long-term survival improves with neoadjuvant checkpoint blockade • Targeted therapy benefits linked to mutation burden • CRISPR screens and toxicity insights refine immunotherapy strategy pir.sh/rk915wQanp #Melanoma #Immunotherapy #TargetedTherapy #CancerResearch

🧪 Liquid Biopsy — Jan 2026 • Post-treatment ctDNA predicts recurrence across multiple cancers • Baseline mutation status refines prognosis in advanced disease • CTCs and EV-derived signals guide therapy response pir.sh/A5kgYmGg4m #LiquidBiopsy #ctDNA #PrecisionOncology #CancerDiagnostics

🧠 Microglia — Jan 2026 • TREM2 and metabolic rewiring influence neurodegeneration • Infectious and inflammatory triggers amplify CNS immune signaling • Microglia-targeted therapies gain momentum in neurodegenerative disease pir.sh/qmxdxQyayp #Microglia #Neuroinflammation #Neurodegeneration

📊 Bioinformatics - Jan 2025 • Population-scale modeling maps the tumor immune microenvironment • RNA–small molecule prediction advances structure-free drug discovery • Improved microbiome analytics refine association testing pir.sh/9OxdzbYdBl #Bioinformatics #ComputationalBiology

🧬 Gene Editing — Jan 2026 • CRISPR-Cas3 enables high-efficiency hepatic editing in vivo • Advanced base editors expand precision mutagenesis capacity • CAR-T approaches extend into autoimmune disease #GeneEditing #CRISPR #CellTherapy pir.sh/zZXgkVNa2M

🩺 Nephrology — Jan 2025 • Gene-edited pig kidneys reveal complex immune responses • eGFR and family history refine CKD progression risk • SGLT2i and RNA therapies shift treatment strategies pir.sh/0D3aPkJdlx #Nephrology #Kidneydisease #CKD

🩺 Nephrology — Dec 2025 • Autoimmunity and complement activation drive glomerular injury • Mixed results for metabolic and GLP-1–based kidney interventions • Gene and base editing show promise in inherited kidney disease pir.sh/yjEaOYL1vM #Nephrology #KidneyDisease

📊 Bioinformatics - Dec 2025 • GigaTIME AI-driven framework scale tumor and immune microenvironment modeling • Expanded classifiers refine cancer taxonomy • CellSAM Universal model improve cell segmentation across image modalities pir.sh/MJnglvnd0L #Bioinformatics #ComputationalBiology #Genomics

Extracellular Vesicles - Dec 2025 🧪 • Vesicle signaling linked to cancer progression and therapy resistance • Exosome liquid biopsies show high accuracy for early cancer detection • Engineered vesicles improve drug delivery pir.sh/QMZgmwGdL5 #ExtracellularVesicles #Exosomes #LiquidBiopsy

🧠 Glioblastoma — Dec 2025 • Antigen heterogeneity and sparse targets explain past immunotherapy failures • Systemic therapies continue to show limited benefit in recurrent disease • Liquid biopsy make diagnostic and surgical progress pir.sh/A5kgYNj14m #Glioblastoma #NeuroOncology #BrainTumors

summarized.science grew out of my own need to keep up with biomedical research without burning too much time on individual papers. Using AI, the site publishes monthly, topic-level summaries of peer-reviewed literature to highlight impactful research 🚀. Topic suggestions are welcome!

🧬 Melanoma — Dec 2025 • Nanoparticles and oncogene targeting open new therapeutic angles • Immune cell senescence and dosing trade-offs shape immunotherapy outcomes • ctDNA and blood-based tests improve monitoring of metastatic disease pir.sh/rk9152bdnp #Melanoma #CancerImmunology #SkinCancer